Table 1.
Baseline characteristics of 64 patients with acute traumatic spinal cord injury who received progesterone and vitamin D or placebo
| Progesterone + Vitamin D (n = 32) | Placebo (n = 32) | P-value | |
|---|---|---|---|
| Age (years) | 41.88 ± 13.6 | 45.2 ± 13.7 | 0.341 |
| Sex | |||
| Male (%) | 19 (56.2%) | 16 (50.0%) | 0.802 |
| Female (%) | 14 (43.8%) | 16 (50.0%) | |
| Injury Severity Score | 28.9 ± 8.9 | 30.6 ± 9.4 | 0.224 |
| Time between injury and intervention (hr) | 3.62 ± 1.75 | 3.53 ± 1.83 | 0.835 |
| ≤4 hours | 23 (71.9%) | 22 (68.7%) | 0.609 |
| >4 hours | 9 (28.1%) | 10 (31.3%) | |
| Fracture site | |||
| Cervical | 7 (21.9%) | 6 (18.8%) | 0.652 |
| C4 (%) | 3 (9.4%) | 0 (0.0%) | |
| C5 (%) | 0 (0.0%) | 3 (9.4%) | |
| C6 (%) | 4 (12.5%) | 0 (0.0%) | |
| C7 (%) | 0 (0.0%) | 3 (9.4%) | |
| Thoracic | 19 (59.5%) | 19 (59.5%) | 0.998 |
| T1 (%) | 0 (0.0%) | 3 (9.4%) | |
| T2 (%) | 3 (9.4%) | 0 (0.0%) | |
| T4 (%) | 2 (6.2%) | 3 (9.4%) | |
| T5 (%) | 0 (0.0%) | 4 (12.5%) | |
| T6 (%) | 3 (9.4%) | 0 (0.0%) | |
| T11 (%) | 3 (9.4%) | 6 (18.8%) | |
| T12 (%) | 8 (25.0%) | 3 (9.4%) | |
| Lumbar | 6 (18.8%) | 7 (21.9%) | 0.652 |
| L1 (%) | 6 (18.8%) | 4 (12.5%) | |
| L2 (%) | 0 (0.0%) | 3 (9.4%) | |
| Treatment | |||
| Surgery (%) | 12 (37.5%) | 10 (31.2%) | 0.793 |
| Conservative (%) | 20 (62.5%) | 22 (68.8%) |